 |
5ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬”-GAATATTAACAIACTGACAAGTC-3ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬” |
|---|---|
| Trade Name | |
| Orphan Indication | Prophylaxis following documented or suspected exposure to marburg virus |
| USA Market Approval | USA |
| USA Designation Date | 2012-10-31 00:00:00 |
| Sponsor | Sarepta Therapeutics, Inc.;215 First Street, Suite 415;Cambridge, Massachusetts, 02142 |
